Welcome to the HBOT News Network
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
The NBA star shows Architectural Digest the dedicated self-care space in his Cleveland, Ohio home that includes a hyperbaric chamber. Read the full story on Architectural Digest:...
Listen to Dr. Paul Harch discuss the double standard in medicine, randomized controlled trials versus evidence based medicine as it relates to the use of ventilators, hydroxyclhoriquine, and hyperbaric oxygen therapy for the treatment...
Effectiveness of Hyperbaric Oxygen Therapy for Traumatic Brain Injury: Interview of Paul G. Harch, MD
Nancy Faass interviews Dr. Paul Harch on the Effectiveness of Hyperbaric Oxygen Therapy for Traumatic Brain Injury. In the treatment of traumatic brain injury, the research suggests that hyperbaric oxygen is the most effective therapy...
Christie DeBernardis visits the Kentucky Equine Sports Medicine and Rehabilitation Center to see a Jack Russell Terrier receive a hyperbaric oxygen therapy treatment and learns much more about how HBOT and other therapies are used by...
Hyberbaric Oxygen Treatments have been used for years to treat issues such as anemia, bubbles of air in your blood vessels, and carbon monoxide, just to name a few (according to the Mayo Clinic).But now, it's being used in the fight...
Thomas E Serena, MD of the SerenaGroup, Inc. with the Wound Treatment Center at Opelousas General Hospital in Louisiana have begun a new clinical trial to study COVID-19 patients treated with Hyperbaric Oxygen Therapy under...
Using Hyperbaric Oxygen Therapy for Coronavirus Lung Infection: The time for more HBOT treatment and studies is now
Dr. Paul Harch shares his thoughts on off-label treatment of COVID-19 with HBOT as well as the Institutional Review Board (IRB) approved protocol used for the study he is conducting with the Louisiana State University.For months, the...
HBOT for coronavirus pneumonia and respiratory failure is now being applied to patients around the world clinically and in experimental trials. Dr. Harch explains how it works by answering the question "What is HBOT?" and showing that...
What is “Off-label” Use of HBOT?Hyperbaric oxygen chambers are medical devices that are cleared for marketing and use by the Food and Drug Administration (FDA) for 13 indications, based on a list originally compiled by the Undersea and...
Recent Hyperbaric Oxygen Therapy (HBOT) Research
Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis.
Abstract: BackgroundPrevious studies have shown that hyperbaric oxygen therapy (HBOT) can improve the motor functions and memory of post-stroke patients in the chronic stage. ObjectiveThe aim of this study is to evaluate the effects of HBOT...
Prospective clinical assessment of 40 Hyperbaric Oxygen (HBO) treatments in 10 completed
Clinical Trial – Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research
In the investigator’s institute there is ongoing treatment of different patients with
cognitive deficits using Hyperbaric oxygen therapy (HBOT). These patients undergo
neuro-cognitive function computerized tests before and after treatment.
The aim of this study was to retrospectively evaluate the cognitive changes before and after
HBOT in different patients populations.
VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration
Abstract: Hyperbaric oxygen (HBO) treatment promotes early recovery from muscle injury. Reactive oxygen species (ROS) upregulation is a key mechanism of HBO, which produces high O2 content in tissues through increased dissolution of oxygen at high...
The objective of this study is to compare the incidence of postoperative urinary retention
related to spinal anesthesia with morphine and spinal anesthesia associated with peripheral
blockade in orthopedic procedures of lower limbs. Secondary objectives are assessing the
incidence of nausea and vomiting; postoperative pain and opioid consumption at 24 hours after
surgery with each of the techniques. A total of 52 patients submitted to a lower limb
orthopedic procedure were randomized to the intervention groups: spinal anesthesia with
morphine versus spinal anesthesia without opioid associated with peripheral nerve block.
After surgery, bladder ultrasound will be performed in post-anesthesia care unit to identify
urinary retention and patients will be followed for 24 hours to assess outcomes.
Clinical Trial – Autonomic Modulation After Spinal Anesthesia With Depth of Anesthesia and Vital Signs.
Spinal anaesthesia has the advantage that produced nerve block by the injection of local
anaesthetic into cerebrospinal fluid (CSF). However, the greatest challenge in spinal
anaesthesia is to control the spread of local anaesthetic through the CSF to provide a block
which is adequate for the proposed surgery without unnecessary extensive spread, and
increased risk of complications.
The aim of the current study was to examine the effect of short-term HBOT (hyperbaric oxygen
treatments) on a range of cognitive abilities. The current study examined whether there is a
HBOT-related short-term cognitive improvement and, if so, what specific cognitive abilities
are improved by the intervention.
Participants were randomized to perform cognitive tasks in one of two chambers with two
different clinical environments: (a) HBOT condition: (2 ATA (atmosphere absolute) 100% oxygen
for 90 minutes). (b) Control condition: in which the chamber was not pressurized (Normobaric
condition- 1 ATA for 90 minutes).
The purpose of this Research Study is:
1. To determine the reliability and performance of the Dexcom G6® continuous glucose
monitoring (CGM) system in patients with diabetes undergoing hyperbaric oxygen (HBO2)
exposure. The study-specific blood glucose meter and CGM system are approved by the FDA
(U.S. Food and Drug Administration).
2. To determine whether HBO2 exposure causes blood glucose to drop as a result of the
3. To determine whether HBO2 causes a change in blood glucagon (a hormone that raises blood
Investigators will be comparing changes in blood glucose and glucagon in volunteers with
diabetes who will be exposed to a single hyperbaric oxygen treatment (pressurization to 2.4
atmospheres absolute for 90 minutes) to a control period of 2 hours where volunteers will
simulate a hyperbaric treatment while sitting in an examination room breathing room air at
sea level pressure. Investigators will be measuring blood glucose with a variety of devices
including a continuous glucose monitor, two point-of-care glucometers, and the hospital
inpatient laboratory measurement of venous blood.
Abstract: Necrotizing fasciitis and myositis caused by group A streptococci (GAS) are among the most fulminating infections, with a mortality rate of 20% to 30%. Although numerous regimens have been utilized in attempts to control these devastating...